Article
AGR2 – a Novel Predictor of Neoadjuvant Chemoradiotherapy Response in Esophageal Squamous Cell Carcinoma
2021-05-13
Abstract excerpt
<title>Abstract</title> <p>BackgroundEsophageal squamous cell carcinoma (ESCC) still has a poor prognosis despite the use of multidisciplinary therapy. In the locally advanced stage, neoadjuvant chemoradiotherapy (nCRT) followed by surgery might provide survival benefits to some patients. MethodsIn <italic>this study</italic>, we <italic>aimed to identify</italic> biomarker to <italic>predict</italic> tumor respo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e8164fe9-1a69-598e-9937-5cad82fe0f0f
- DOI
- 10.21203/rs.3.rs-501001/v1
